Xense Inc.

Aiming to minimize radiology error of 30% in healthcare delivery, XENSE 's Meta CT /AI  technology offers accurate standardized real time 3D imaging & 3D physical model for healthcare delivery of critical illnesses with ultralow x-ray radiation,  replacing  traditional CT , fluoroscope, general x ray, densitometer and other medical x modalities and related AI solutions  used in prediction, diagnosis and intervention guidance with one AI powered compact device with higher performances previously not possible.  With initial fundings from NASA and Department of Transportation, based on 30+ years of R & D and effort of two generations of engineers/physicist/molecular biologist from MIT,  Harvard Medical School, Columbia University and Boston University, the first Meta CT / AI aims to  minimize radiology errors, dramatically reduce radiation exposure, significantly lowering costs for the healthcare delivery and minimizing time to diagnosis, intervention & wellness. XENSE has filed 70+ and been granted multiple patents in imaging hardware, algorithms, AI and supporting technologies, though its primary products are currently in development and not yet FDA approved for commercial use.